Oncology
For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
See solutionsWHAT WE DO
HOW WE DO IT
Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
See expertiseTherapeutic Expertise
Cross-Therapeutic Expertise
Our experts help you stay at the forefront of the industry - and ahead of change.
See insightsNew Medicines, Novel Insights
Discussions on Diversity
Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
Learn moreFor years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
It took 10 years of treatments for Anisha's IBD to enter remission. But it came back in 2019 — and just as she was about to start treatment, the pandemic hit.
Want to collaborate with us to offer clinical trials at your site? We would welcome the opportunity to discuss.
Learn moreWe are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
About ParexelWhat can we help you find today?
Chris Learn, Head of Cell and Gene COE at Parexel discusses his participation at the recent Clinical Research Virtual Summit hosted by the Society for Immunotherapy of Cancer, and the implications for clinical research.
Related Insights
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
Chris Learn joins Parexel as Head of the Cell and Gene Center of Excellence
Apr 4, 2022
Article
Three ways to improve your chances that insurers will pay for a new CGT
Feb 18, 2021
Blog
We need faster endpoints for targeted cancer drugs, and there is one
Feb 19, 2021
Article
Regulatory, clinical and logistics challenges of ATMPs in clinical research
Apr 22, 2021
Article
Embarking on the Next Era of Precision Medicine
May 11, 2021
Blog
Highlights from ASCO: Our experts weigh in
Jul 13, 2021
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Article
New endpoints for early-stage cancer are gaining regulatory traction
Jan 28, 2022
Video
Cell & Gene Therapies: A Regulatory Update
Jul 22, 2022
Blog
Parexel names first Patient Ambassador
Jun 17, 2022